Expertise in
2
conditions

Rami R. Kotb

Winnipeg, MB, CA 
Expertise in
2
conditions
Winnipeg, MB, CA 

Overview

Rami Kotb practices practicing medicine in Winnipeg, Canada.

Kotb is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Thrombocytopenia, Delayed Growth, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 54 peer reviewed articles and participating in 4 clinical trials.

Locations

Winnipeg, MB, Canada
Other Locations
MB, Canada
BC Cancer Agency's Vancouver Island Centre
Victoria, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
Enrollment Status: Active_not_recruiting
Publish Date: June 29, 2025
A Phase 2A Multi Centre, Open Label, Pilot Study Of Pembrolizumab Added to The Standard First-Line Therapy Of Cyclophosphamide, Bortezomib And Dexamethasone (CyBorD) In Newly Diagnosed Multiple Myeloma Patients Not Eligible For Autologous Stem Cell Transplantation
A Phase 2A Multi Centre, Open Label, Pilot Study Of Pembrolizumab Added to The Standard First-Line Therapy Of Cyclophosphamide, Bortezomib And Dexamethasone (CyBorD) In Newly Diagnosed Multiple Myeloma Patients Not Eligible For Autologous Stem Cell Transplantation
Enrollment Status: Withdrawn
Publish Date: August 29, 2023
Intervention Type: Drug
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide With or Without Pomalidomide in Patients With Relapsed and Refractory Multiple Myeloma
A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide With or Without Pomalidomide in Patients With Relapsed and Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: August 04, 2023
Intervention Type: Biological
Study Drugs: DCdP, DCd+P
Study Phase: Phase 2
Use of FLT-TEP Scan as Predictive Marker and Early Prognostic in Patients Suffering From AML Treated by Chemotherapy
Use of FLT-TEP Scan as Predictive Marker and Early Prognostic in Patients Suffering From AML Treated by Chemotherapy
Enrollment Status: Withdrawn
Publish Date: April 14, 2021
View 3 Less Clinical Trials

54 Total Publications

Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database.
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 19, 2025

Frequently Asked Questions about Rami R. Kotb

Is Rami R. Kotb a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Rami R. Kotb is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rami R. Kotb participate in research or clinical trials?

Yes. Rami R. Kotb has published 54 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Rami R. Kotb's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kotb's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile